(S)-2-((((S)-3-(4-Chlorophenyl)-4-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)(4-Chlorophenylsulfonamido)Methylene)Amino)-3-Methylbutanamide (S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺

CAS 1392116-14-1 MFCD492116141

化学结构图

1392116-14-1
SMILES:

别名和识别编码

Chemical Name Translation(S)-2-((((S)-3-(4-氯苯基)-4-苯基-4,5-二氢-1H-吡唑-1-基)(4-氯苯基磺胺基)亚甲基)氨基)-3-甲基丁酰胺
Chemical Name(S)-2-((((S)-3-(4-Chlorophenyl)-4-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)(4-Chlorophenylsulfonamido)Methylene)Amino)-3-Methylbutanamide
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Knani I, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab. 2016 Oct 22;5(12):1187-1199.
  • [3]. Mukhopadhyay B, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015 May;61(5):1615-26.
  • [1]. Chorvat RJ. Peripherally restricted CB1 receptor blockers. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4751-60.
  • [1]. Chorvat RJ. Peripherally restricted CB1 receptor blockers. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4751-60.
  • [2]. Knani I, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab. 2016 Oct 22;5(12):1187-1199.
  • [3]. Mukhopadhyay B, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015 May;61(5):1615-26.

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. Cannabinoid Receptor  (大麻素受体)

相关产品推荐